James Levine - 09 Mar 2022 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Chief Financial Officer
Signature
/s/ James Levine
Issuer symbol
CRDF
Transactions as of
09 Mar 2022
Net transactions value
$0
Form type
4
Filing time
10 Mar 2022, 17:40:57 UTC
Previous filing
13 Sep 2021
Next filing
19 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRDF Stock Options Award $0 +170,016 +44% $0.000000 560,016 09 Mar 2022 Common Stock 170,016 $2.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 42,504 vest on 3/09/2023. 3,542 vest monthly for 36 months beginning on 4/09/2023 through 3/09/2026.